Novartis AG NVSEF
160.23 USD -0.49 (-0.30%)
At closeNov 5, 2026, 4:00 PM EST
159.20 Day range 160.23
120.00 52-week range 171.29
- YTD
- +16.11%
- 1 year
- +33.52%
- Market cap
- 302.61B
- EPS (ttm)
- 7.93
- P/E ratio
- 20.21
- YTD return
- +16.11%
- 1-year return
- +33.52%
- Volume
- 20
- Avg volume
- 20.87K
- Open
- 159.20
- Previous close
- 160.72
- Day's range
- 159.20 – 160.23
- 52-week range
- 120.00 – 171.29
- Earnings date
- Oct 27, 2026
2Y +48.62 (+43.37%)
Next earnings
Oct 27, 2026
Expected Oct 27, 2026. Consensus EPS estimate 2.23.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 27, 2026 | Sep 30, 2026 | 2.23 | — | — | — |
| Jul 21, 2026 | Jun 30, 2026 | 2.17 | 2.41 | +0.24 | +11.06% |
| Apr 28, 2026 | Mar 31, 2026 | 2.10 | 1.99 | -0.11 | -5.24% |
| Feb 4, 2026 | Dec 31, 2025 | 1.99 | 2.03 | +0.04 | +2.01% |
| Oct 28, 2025 | Sep 30, 2025 | 2.27 | 2.25 | -0.02 | -0.88% |
| Jul 17, 2025 | Jun 30, 2025 | 2.35 | 2.42 | +0.07 | +2.98% |
News
Novartis: Q3 2026 Earnings Confirm 'Hold' Recommendation Based On Balanced Approach 
Novartis: The Sell-Off Creates An Attractive Entry Point 
How To Build A $50,000 Dividend Portfolio In Today's Market 
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer 
Stocks That Hit 52-Week Highs On Wednesday 
Stocks That Hit 52-Week Highs On Wednesday 
Stocks That Hit 52-Week Highs On Friday 
Stocks That Hit 52-Week Highs On Friday - Stocks That Hit 52-Week Highs On Thursday
- Stocks that Broke 52-Week Highs Tuesday
Your note
Sign in to keep a note on NVSEF — it syncs with the Stock Master app.